Article
Double-targeted knockdown of miR-21 and CXCR4 inhibits malignant glioma progression by…
medRxiv · 2020 · Liu F, Yang B.
Key facts
| Title | Double-targeted knockdown of miR-21 and CXCR4 inhibits malignant glioma progression by suppression of the PI3K/AKT and Raf/MEK/ERK pathways |
|---|---|
| First author | Liu F, Yang B. |
| Journal | medRxiv |
| Published | Apr 14, 2020 |
| DOI | 10.1101/2020.04.14.040568 |
| Devices mentioned | 040568 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1